Abstract
Background and Aim
Simultaneous dilatation of the common bile duct and pancreatic duct, “double-duct sign” (DDS), is an ominous finding concerning for pancreaticobiliary malignancy. Little evidence exists to guide the initial evaluation and subsequent follow-up for patients with DDS in the absence of jaundice or focal mass noted on computed tomography (CT)/ magnetic resonance imaging (MRI). Endoscopic ultrasound (EUS) is often recommended in the evaluation of such patients, however, the prevalence of malignancy remains unclear. We sought to determine the prevalence of pancreaticobiliary neoplasm in this patient group on initial EUS evaluation and on subsequent clinical follow-up.
Methods
We performed a retrospective analysis of a prospective database at a tertiary-care academic medical center between 2010 and 2012. Eighty-two patients were identified who underwent EUS evaluation for DDS without evidence of a mass on CT/MRI and without jaundice.
Results
Sixty-eight of 82 patients had confirmed DDS on EUS with biductal dilation. Six (9 %) of 68 patients were found to have a mass lesion on EUS. In these patients, final diagnoses were pancreatic carcinoma (n = 4), ampullary carcinoma (n = 1) and ampullary adenoma (n = 1). In the 62 patients without evidence of a focal mass on initial EUS, the most common diagnoses were benign ductal dilation (n = 42), chronic pancreatitis (n = 9) and choledocholithiasis (n = 8). Fifty-eight (94 %) of 62 patients had documented median follow-up of 13 months, and none developed subsequent evidence of previously unrecognized malignancy.
Conclusions
The presence of double-duct sign on EUS in patients without jaundice or mass lesion on CT/MRI is most frequently associated with benign conditions. When a mass is not detected on EUS, subsequent evidence of malignancy is unlikely.
Similar content being viewed by others
References
Freeny PC, Bilbao MK, Katon RM. “Blind” evaluation of endoscopic retrograde cholangiopancreatography (ERCP) in the diagnosis of pancreatic carcinoma: the “double duct” and other signs. Radiology. 1976;119:271–274.
Plumley TF, Rohrmann CA, Freeny PC, Silverstein FE, Ball TJ. Double duct sign: reassessed significance in ERCP. Am J Roentgenol. 1982;138:31–35.
Ahualli J. The double duct sign. Radiology. 2007;244:314–315.
Baillie J, Paulson EK, Vitellas KM. Biliary imaging: a review. Gastroenterology. 2003;124:1686–1699.
Menges M, Lerch MM, Zeitz M. The double duct sign in patients with malignant and benign pancreatic lesions. Gastrointest Endosc. 2000;52:74–77.
Sharma M, Mahadevan B. An unusual cause of double duct sign. Type I sphincter of Oddi dysfunction due to chronic opium addiction. Gastroenterology. 2011;140:e1–e2.
Edge MD, Hoteit M, Patel AP, Wang X, Baumgarten DA, Cai Q. Clinical significance of main pancreatic duct dilation on computed tomography: single and double duct dilation. World J Gastroenterol. 2007;13:1701–1705.
Krishna N, Tummala P, Reddy AV, Mehra M, Agarwal B. Dilation of both pancreatic duct and the common bile duct on computed tomography and magnetic resonance imaging scans in patients with or without obstructive jaundice. Pancreas. 2012;41:767–772.
Carriere V, Conway J, Evans J, Shokoohi S, Mishra G. Which patients with dilated common bile and/or pancreatic ducts have positive findings on EUS? J Interv Gastroenterol. 2012;2:168–171.
Tanaka S, Nakaizumi A, Ioka T, et al. Main pancreatic duct dilatation: a sign of high risk for pancreatic cancer. Jpn J Clin Oncol. 2002;32:407–411.
Tanaka S, Nakao M, Ioka T, et al. Slight dilatation of the main pancreatic duct and presence of pancreatic cysts as predictive signs of pancreatic cancer: a prospective study. Radiology. 2010;254:965–972.
Sirli R, Sporea I. Ultrasound examination of the normal pancreas. Medical Ultrasonogr. 2010;12:62–65.
Feng B, Song Q. Does the common bile duct dilate after cholecystectomy? Sonographic evaluation in 234 patients. Am J Roentgenol. 1995;165:859–861.
Reinus WR, Shady K, Lind M, Scott R. Ultrasound evaluation of the common duct in symptomatic and asymptomatic patients. Am J Gastroenterol. 1992;87:489–492.
Coss A, Enns R. The investigation of unexplained biliary dilatation. Curr Gastroenterol Rep. 2009;11:155–159.
Erickson RA. EUS-guided FNA. Gastrointest Endosc. 2004;60:267–279.
Lin F, Staerkel G. Cytologic criteria for well differentiated adenocarcinoma of the pancreas in fine-needle aspiration biopsy specimens. Cancer. 2003;99:44–50.
Bounds BC. Diagnosis and fine needle aspiration of intraductal papillary mucinous tumor by endoscopic ultrasound. Gastrointest Endosc Clin N Am. 2002;12:735–745.
Agarwal B, Krishna NB, Labundy JL, Safdar R, Akduman EI. EUS and/or EUS-guided FNA in patients with CT and/or magnetic resonance imaging findings of enlarged pancreatic head or dilated pancreatic duct with or without a dilated common bile duct. Gastrointest Endosc. 2008;68:237–242. quiz 334, 5.
Malik S, Kaushik N, Khalid A, et al. EUS yield in evaluating biliary dilatation in patients with normal serum liver enzymes. Dig Dis Sci. 2007;52:508–512.
Andersen HB, Effersoe H, Tjalve E, Burcharth F. CT for assessment of pancreatic and periampullary cancer. Acta Radiol. 1993;34:569–572.
Pasanen PA, Partanen KP, Pikkarainen PH, Alhava EM, Janatuinen EK, Pirinen AE. A comparison of ultrasound, computed tomography and endoscopic retrograde cholangiopancreatography in the differential diagnosis of benign and malignant jaundice and cholestasis. Europ J Surgery. 1993;159:23–29.
Muller MF, Meyenberger C, Bertschinger P, Schaer R, Marincek B. Pancreatic tumors: evaluation with endoscopic US, CT, and MR imaging. Radiology. 1994;190:745–751.
Mackillop W. Toward Canadian Benchmarks for waiting times for radiotherapy for cancer: Synthesizing the evidence and establishing research priorities—review on tumour doubling time 2008.
Acknowledgments
The authors would like to acknowledge Shannon Drew for her assistance with technical support as well as Dr. Kenneth Mukamal and Dr. Gordon Strewler for their support of this research.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cohen, J., Sawhney, M.S., Pleskow, D.K. et al. Double-Duct Sign in the Era of Endoscopic Ultrasound: The Prevalence of Occult Pancreaticobiliary Malignancy. Dig Dis Sci 59, 2280–2285 (2014). https://doi.org/10.1007/s10620-014-3133-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-014-3133-3